Syngene International Limited (NSE:SYNGENE)
629.20
-19.60 (-3.02%)
Aug 28, 2025, 3:30 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 258.26 billion as of August 28, 2025. Its market cap has decreased by -22.82% in one year.
Market Cap
258.26B
Enterprise Value
250.07B
Revenue
37.27B
Ranking
n/a
PE Ratio
54.53
Stock Price
629.20
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 258.26B, an increase of 315.81%. That is a compound annual growth rate of 15.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 26, 2025 | 258.26B | -24.35% |
Dec 31, 2024 | 341.40B | 22.54% |
Dec 29, 2023 | 278.60B | 19.79% |
Dec 30, 2022 | 232.57B | -5.39% |
Dec 31, 2021 | 245.81B | -3.08% |
Dec 31, 2020 | 253.62B | 100.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,839.66B |
Divi's Laboratories | 1,643.38B |
Cipla | 1,276.09B |
Apollo Hospitals Enterprise | 1,120.59B |
Mankind Pharma | 1,032.72B |
Zydus Lifesciences | 994.01B |
Fortis Healthcare | 691.54B |
Alkem Laboratories | 648.28B |